4/A//SEC Filing
FREEMAN KEVIN D 4/A
Accession 0001133416-22-000010
CIK 0001133416other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 11:18 AM ET
Size
6.0 KB
Accession
0001133416-22-000010
Insider Transaction Report
Form 4/AAmended
FREEMAN KEVIN D
Director
Transactions
- Purchase
Common Stock
2022-01-19$1.96/sh+5,000$9,806→ 55,000 total(indirect: By LLC)
Holdings
- 23,469
Common Stock
- 16,000(indirect: By IRA)
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeother
Related Parties
1- filerCIK 0001522478
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 11:18 AM ET
- Size
- 6.0 KB